Studijní program
Publikace
- Superiority of ceftazidime off-label high-dose regimen in PK/PD target attainment during treatment of extensively drug-resistant Pseudomonas aeruginosa infections in cancer patients2023 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové, Farmaceutická fakulta v Hradci Králové
- Pulmonary damage in a patient with hairy cell leukemia - infectious involvement or hematological disease activity? Case report2023 | Lékařská fakulta v Hradci Králové, Farmaceutická fakulta v Hradci Králové
- Better Outcome of Off-Label High-Dose Ceftazidime in Hemato-Oncological Patients with Infections Caused by Extensively Drug-Resistant Pseudomonas Aeruginosa2023 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
- The impact of sharing a home with a pet on the physiological state of the human microbiome: a comprehensive study on the Czech population with a focus on filamentous fungi2023 | 2. lékařská fakulta, Lékařská fakulta v Hradci Králové
- COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)2023 | Lékařská fakulta v Plzni
- A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first-line therapy administration in patients with chronic lymphocytic leukemia2023 | Lékařská fakulta v Hradci Kr álové
- Imunitní deregulace u myelodysplastických syndromů - role cytokinů a solubilních adhezních molekul. Pilotní studie2023 | Lékařská fakulta v Hradci Králové
- Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)2023 | Lékařská fakulta v Hradci Králové
- Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial2023 | Publikace bez příslušnosti k fakultě
- Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry2023 | Publikace bez příslušnosti k fakultě
Loading network view...
